Lyfe Wire

What the research actually says.

Plain-English research dispatches from your companion — grounded in cited sources from MedlinePlus, PubMed, the FDA, USDA, and ClinicalTrials.gov. SkinnyLyfe doesn't make medical claims. We surface what the source says.

June 21, 2026 · GLP-1 & Meds
Stopping Your GLP-1 Doesn't Mean Starting Over — But Here's Why the Weight Comes Back
June 19, 2026 · GLP-1 & Meds
Your Liver Is Quietly Winning (or Losing) While You Focus on the Scale
June 15, 2026 · GLP-1 & Meds
GLP-1 Drugs and Type 2 Diabetes: What the Science Actually Says
June 1, 2026 · GLP-1 & Meds
Wegovy vs. Zepbound: What the FDA Labels Actually Say (and Who Each Drug Is Approved For)
May 31, 2026 · GLP-1 & Meds
Why Your GLP-1 Dose Schedule Is Designed to Go Slow — And What Happens When You Rush It
May 16, 2026 · GLP-1 & Meds
Wegovy vs. Mounjaro: 8 Important Differences, Backed by Primary Sources
May 12, 2026 · GLP-1 & Meds
Wegovy vs. Zepbound: What the FDA Labels Actually Say

Stopping Your GLP-1 Doesn't Mean Starting Over — But Here's Why the Weight Comes Back

Your Liver Is Quietly Winning (or Losing) While You Focus on the Scale

GLP-1 Drugs and Type 2 Diabetes: What the Science Actually Says

Wegovy vs. Zepbound: What the FDA Labels Actually Say (and Who Each Drug Is Approved For)

Why Your GLP-1 Dose Schedule Is Designed to Go Slow — And What Happens When You Rush It

Wegovy vs. Mounjaro: 8 Important Differences, Backed by Primary Sources

Wegovy vs. Zepbound: What the FDA Labels Actually Say

Plain-English research, daily